Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
57
CEMX.TO Quote, Financials, Valuation and Earnings
Last price:
$0.36
Seasonality move
:
9.71%
Day range:
$0.36 - $0.37
52-week range:
$0.16 - $0.40
Dividend yield:
0%
P/E ratio:
17.82x
P/S ratio:
1.28x
P/B ratio:
1.38x
Volume:
103.1K
Avg. volume:
122.9K
1-year change:
67.44%
Market cap:
$54.1M
Revenue:
$35.4M
EPS (TTM):
$0.02
Analysts' Opinion
-
Consensus RatingCematrix Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $0.65, Cematrix Corp. has an estimated upside of 80.56% from its current price of $0.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $0.65 representing 100% downside risk from its current price of $0.36.
Fair Value
-
According to the consensus of 1 analyst, Cematrix Corp. has 80.56% upside to fair value with a price target of $0.65 per share.
CEMX.TO vs. S&P 500
-
Over the past 5 trading days, Cematrix Corp. has underperformed the S&P 500 by -2.53% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cematrix Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cematrix Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Cematrix Corp. reported revenues of $15.3M.
Earnings Growth
-
Cematrix Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Cematrix Corp. reported earnings per share of $0.01.
Enterprise value:
47.9M
EV / Invested capital:
--
Price / LTM sales:
1.28x
EV / EBIT:
12.20x
EV / Revenue:
1.12x
PEG ratio (5yr expected):
0.21x
EV / Free cash flow:
84.98x
Price / Operating cash flow:
97.08x
Enterprise value / EBITDA:
7.63x
Gross Profit (TTM):
$13.4M
Return On Assets:
6.96%
Net Income Margin (TTM):
7.22%
Return On Equity:
8.36%
Return On Invested Capital:
7.6%
Operating Margin:
18.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $42M | $44.6M | $42.9M | $10.1M | $15.3M | |
| Gross Profit | $6.7M | $11.4M | $13.4M | $2.7M | $5.2M | |
| Operating Income | -$1.3M | $1.6M | $3.9M | $601K | $2.8M | |
| EBITDA | $848K | $3.8M | $6.3M | $1.2M | $3.4M | |
| Diluted EPS | -$0.02 | $0.01 | $0.02 | $0.00 | $0.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $28M | $22.8M | $17.8M | $19.8M | $26.7M | |
| Total Assets | $47.4M | $44.3M | $39.3M | $42.3M | $50.1M | |
| Current Liabilities | $5.3M | $11.1M | $9.3M | $4M | $7M | |
| Total Liabilities | $14.3M | $15.4M | $12.1M | $6.9M | $10.8M | |
| Total Equity | $33.1M | $28.9M | $27.2M | $35.4M | $39.3M | |
| Total Debt | $9M | $8.2M | $3.5M | $3.6M | $3.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.9M | $5M | $2.9M | -$1.3M | $1.7M | |
| Cash From Investing | -$2.1M | -$639K | -$2.6M | -$14K | -$94K | |
| Cash From Financing | -$5.2M | $3.6M | -$389K | $5.7M | -$217K | |
| Free Cash Flow | -$5.1M | $4.4M | $564K | -$1.4M | $1.6M | |
CEMX.TO
Sector
Market Cap
$54.1M
$23.7M
Price % of 52-Week High
90%
72.22%
Dividend Yield
0%
0%
Shareholder Yield
0.02%
-2.98%
1-Year Price Total Return
67.44%
20%
Beta (5-Year)
-0.127
0.594
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.36
200-day SMA
Buy
Level
$0.32
Bollinger Bands (100)
Buy
Level
0.33 - 0.37
Chaikin Money Flow
Buy
Level
39.3K
20-day SMA
Sell
Level
$0.36
Relative Strength Index (RSI14)
Buy
Level
51.37
ADX Line
Sell
Level
12.28
Williams %R
Neutral
Level
-50
50-day SMA
Buy
Level
$0.35
MACD (12, 26)
Buy
Level
0.10
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Sell
Level
-99.2K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.3983)
Buy
CA Score
(Annual)
Level (1.2166)
Buy
Beneish M-Score
(Annual)
Level (-3.4341)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.4303)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cematrix Corp. engages in the manufacturing and supplying cellular concrete products with applications in numerous infrastructure construction-based markets throughout North America. Its cellular concrete products are used in retaining wall, bridge approach backfill, roadways and runways, and slope stabilization, oil and gas facilities, shallow utilities, and thermal remediation, and tunnel grout, slipline and annular grout, pipe abandonment, and flowable fills applications. The company was founded by Jeffrey N. Kendrick in 1999 and is headquartered in Calgary, Canada.
Stock Forecast FAQ
In the current month, CEMX.TO has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CEMX.TO average analyst price target in the past 3 months is $0.65.
-
Where Will Cematrix Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cematrix Corp. share price will rise to $0.65 per share over the next 12 months.
-
What Do Analysts Say About Cematrix Corp.?
Analysts are divided on their view about Cematrix Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cematrix Corp. is a Sell and believe this share price will drop from its current level to $0.65.
-
What Is Cematrix Corp.'s Price Target?
The price target for Cematrix Corp. over the next 1-year time period is forecast to be $0.65 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CEMX.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cematrix Corp. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of CEMX.TO?
You can purchase shares of Cematrix Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cematrix Corp. shares.
-
What Is The Cematrix Corp. Share Price Today?
Cematrix Corp. was last trading at $0.36 per share. This represents the most recent stock quote for Cematrix Corp.. Yesterday, Cematrix Corp. closed at $0.36 per share.
-
How To Buy Cematrix Corp. Stock Online?
In order to purchase Cematrix Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CEMX.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CEMX.TO
Sector
P/E ratio
17.82x
19.88x
PEG ratio
0.21x
-0.02x
P/B ratio
1.38x
1.85x
Price / LTM sales
1.28x
1.65x
Growth Metrics
CEMX.TO
Sector
Revenue growth
51.07%
2.4%
Earnings growth
158.33%
--
Revenue (5-year growth)
9.42%
3.24%
Earnings forecast
--
$0.03
Profitability
CEMX.TO
Sector
Profitability FY 2024
$9.1M
--
Return on invested capital
7.6%
-9.18%
Return on assets
6.96%
-10.59%
Return on equity
8.36%
-9.79%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
CEMX.TO
Sector
Total cash
$9.9M
$2.6M
Short term investments
--
$217K
Total assets
$43.4M
$16.7M
Long term debt
$3.8M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
51
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
75
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
